Titan Pharmaceuticals Inc (TTNP)

[Doctor Detroit]

Favorite quotation:

Now that FDA approval is official, drugmakers are also looking at expanded uses for probuphine, including its future potential as an opioid alternative for patients with chronic pain.

“We’ve had a lot of interest from clinicians who told us that they already use buprenorphine for pain in some instances,” says Sheldon, noting that the opioid alternative is far less addictive in many instances than traditional prescription painkillers. Braeburn aims to start talks with the FDA around probuphine’s use for chronic pain immediately, but the testing involved in pushing that next approval endeavor is likely to take a few years.